Psychology Today

6 Ways Trauma Shows Up in Your Parenting Every Single Day

Why do you explode over tiny things while other parents stay calm? The answer may lie in how unprocessed trauma creates ...

GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update

Cash and cash equivalents totaled €107.5 million as of June 30, 2025, excluding the €26.5 million milestone invoiced in May 2025 (received in ...
The Manila Times

PhenQ Australia Over the Counter | Fast Acting Fat Burner and Appetite Suppressant Australian Launch OTC by PhenQ

Widely regarded as arguably the best OTC fat burner and appetite suppressant pill, PhenQ helps users tackle fat loss from ...

Guerbet : H1 2025 results : H1 revenue: €387.8 million, down 5.4% at CER and on a like-for-like basis, mainly due to the decline in activity in France

H1 2025 results Activity and profitability H1 revenue: €387.8 million, down 5.4% at CER1 and on a like-for-like basis2, mainly due to the ...
The Manila Times

CaptivatingU Med Spa Provides Botox in Cincinnati with Board Certified Specialists

Patients achieve consistent results as CaptivatingU Med Spa provides Botox in Cincinnati with one board-certified specialist ...

Bylvay® (odevixibat) approved in Japan for rare liver disease PFIC

Bylvay® is the first once-daily ileal bile acid transport inhibitor to be approved as a treatment for pruritus associated ...

GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD

Zurich (Switzerland), September 19, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, ...

Ipsen Pharma: Bylvay (odevixibat) approved in Japan for rare liver disease PFIC

Bylvay® is the first once-daily ileal bile acid transport inhibitor to be approved as a treatment for pruritus associated with progressive familial intrahepatic cholestasis (PFIC) in Japan, offering a ...